Carbapenems

Study Identifies Unique Mechanisms of Antibiotic Resistance

As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms of a clinical isolate of E. coli resistant to ...More
March 26, 2013
Posted in News
CRE May Endure in Patients One Year After Initial Infection, Study Finds

Patients who tested positive for carbapenem-resistant Enterobacteriaceae (CRE) took an average of 387 days following hospital discharge to be clear of the organism, according to a new study published in the March 2013 issue of the American Journal of Infection Control. The ...More
February 27, 2013
Posted in News
Clinical Outcomes, Risk Factors Associated with Carbapenem-Resistant Klebsiella Pneumoniae Infection

Healthcare-associated infections caused by Klebsiella pneumoniae isolates are increasing and few effective antibiotics are currently available to treat patients. Correa, et al. (2013) observed decreased carbapenem susceptibility among K. pneumoniae isolated from patients at ...More
February 13, 2013
Posted in News
Investigators Review Studies on Treatment of Klebsiella Pneumoniae Carbapenemase Infections

The emergence of Klebsiella pneumoniae carbapenemases (KPCs) producing bacteria has become a significant global public health challenge while the optimal treatment remains undefined. Lee and Burgess (2012) performed a systematic review of published studies and reports of ...More
February 6, 2013
Posted in News
Self-Prescription of Antibiotics Boosts Superbugs Epidemic in Europe

Antibiotics kill bacteria, not viruses. Viruses, which antibiotics do not affect, cause 9 out of 10 sore throats and 10 out of 10 cases of influenza. Taking antibiotics unnecessarily weakens their ability to work against infections when they are needed. This enables ...More
November 19, 2012
Posted in News
Understanding Antibiotic Resistance Using Crystallography and Computation

Scientists at the University of Bristol, together with collaborators at the University of Aveiro, Portugal, have solved the structure of an enzyme that breaks down carbapenems, antibiotics of last resort which, until recently, were kept in reserve for serious infections ...More
November 12, 2012
Posted in News
Florida Stops Outbreak of Carbapenem-Resistant Enterobacteriaceae

In early 2011, the Centers for Disease Control and Prevention (CDC) sent a team of disease detectives to Florida to assist the state and a healthcare facility stop an outbreak of carbapenem-resistant Enterobacteriaceae, deadly pathogens that cause healthcare-associated ...More
September 18, 2012
Posted in News, PPE & Standard Precautions
Patients on Maintenance Hemodialysis are Susceptible to ESBL-Producing Klebsiella pneumoniae

Hemodialysis (HD) patients are susceptible to extended spectrum beta-lactamase (ESBL)-producing bacterial infections. Because the optimal treatment and clinical significance of ESBL-producing Klebsiella pneumoniae (ESBL-Kp) HD access-related bacteremia remain unclear, Yang, ...More
September 5, 2012
Posted in News
CDC Experts Outline Steps to Prevent the Transmission of Carbapenem-Resistant Enterobacteriaceae

Today on Medscape, Centers for Disease Control and Prevention (CDC) experts Drs. Raymund Dante and Alice Guh provide step-by-step guidance for healthcare professionals that can help protect their patients by preventing the transmission of carbapenem-resistant ...More
June 21, 2012
Posted in News, Hand Hygiene, PPE & Standard Precautions
Slide Show: Preventing CRE Infections

ICT presents highlights from the 2012 CRE Toolkit - Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE), issued by the Centers for Disease Control and Prevention (CDC). ...More
June 21, 2012
Posted in Galleries, Hand Hygiene, PPE & Standard Precautions